Iain S. Mcgregor
#184,538
Most Influential Person Across History
Iain S. Mcgregor's AcademicInfluence.com Rankings
Download Badge
Biology
Iain S. Mcgregor's Degrees
- Bachelors Biology University of California, Davis
- PhD Ecology University of California, Davis
Similar Degrees You Can Earn
Why Is Iain S. Mcgregor Influential?
(Suggest an Edit or Addition)Iain S. Mcgregor's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The effects of predator odors in mammalian prey species: A review of field and laboratory studies (2005) (711)
- ‘When a rat smells a cat’: the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor (2001) (480)
- Defensive behavior in rats towards predatory odors: a review (2001) (422)
- Adolescent Rats Find Repeated Δ9-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure (2008) (288)
- Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats (2004) (280)
- Breaking the loop: Oxytocin as a potential treatment for drug addiction (2012) (249)
- Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. (1999) (247)
- Not all ‘predator odours’ are equal: cat odour but not 2,4,5 trimethylthiazoline (TMT; fox odour) elicits specific defensive behaviours in rats (2002) (237)
- A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (“ecstasy”) (2007) (226)
- Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats (2006) (225)
- Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat (1997) (214)
- Neural Correlates of Cat Odor-Induced Anxiety in Rats: Region-Specific Effects of the Benzodiazepine Midazolam (2004) (214)
- Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011 (2013) (210)
- The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716 (1999) (202)
- Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. (2014) (201)
- Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues. (2016) (183)
- From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long‐term adverse consequences of drug use? (2008) (174)
- Aversive effects of the synthetic cannabinoid CP 55,940 in rats (1996) (173)
- Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. (2015) (170)
- Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats (2011) (167)
- A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. (2010) (159)
- Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. (2015) (154)
- TMT-induced autonomic and behavioral changes and the neural basis of its processing (2005) (150)
- Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile (2013) (148)
- The cardiovascular and behavioral response to cat odor in rats: unconditioned and conditioned effects 1 1 Published on the World Wide Web on 27 February 2001. (2001) (143)
- The direct actions of cannabidiol and 2‐arachidonoyl glycerol at GABAA receptors (2017) (141)
- Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro (1999) (135)
- Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). (2001) (134)
- Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats (2010) (132)
- Adolescent Oxytocin Exposure Causes Persistent Reductions in Anxiety and Alcohol Consumption and Enhances Sociability in Rats (2011) (128)
- Acute Prosocial Effects of Oxytocin and Vasopressin When Given Alone or in Combination with 3,4-Methylenedioxymethamphetamine in Rats: Involvement of the V1A Receptor (2013) (123)
- Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus (2010) (120)
- Increased Anxiety 3 Months after Brief Exposure to MDMA (‘Ecstasy’) in Rats: Association with Altered 5-HT Transporter and Receptor Density (2003) (120)
- Cat odor, but not trimethylthiazoline (fox odor), activates accessory olfactory and defense-related brain regions in rats (2008) (113)
- (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. (2000) (112)
- Low-Dose Midazolam Attenuates Predatory Odor Avoidance in Rats (1999) (107)
- MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks (2000) (107)
- Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. (2004) (106)
- Habituation of the hiding response to cat odor in rats (Rattus norvegicus). (1999) (106)
- A double‐blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome (2014) (105)
- Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. (2002) (105)
- Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition (2019) (105)
- A meta-analysis on the impact of alcohol dependence on short-term resting-state heart rate variability: implications for cardiovascular risk. (2013) (104)
- The first CNS-active carborane: A novel P2X7 receptor antagonist with antidepressant activity. (2014) (100)
- Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats (2004) (100)
- Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes (2003) (95)
- Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference (2012) (94)
- The distribution of 3,4-methylenedioxymethamphetamine “Ecstasy”-induced c-fos expression in rat brain (1999) (94)
- Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test (2011) (94)
- MDMA (“ecstasy”), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat (2004) (94)
- Metabolic effects of neuropeptide Y injections into the paraventricular nucleus of the hypothalamus (1990) (93)
- Chronic Fluoxetine Treatment Partly Attenuates the Long-Term Anxiety and Depressive Symptoms Induced by MDMA (‘Ecstasy’) in Rats (2004) (88)
- Mephedrone (4‐methylmethcathinone, ‘meow’): acute behavioural effects and distribution of Fos expression in adolescent rats (2012) (87)
- Possible neural substrates of beer-craving in rats (1998) (87)
- Cannabinoid modulation of rat pup ultrasonic vocalizations. (1996) (87)
- High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: Neural consequences and comparison with methamphetamine (2013) (86)
- A brief history of oxytocin and its role in modulating psychostimulant effects (2013) (86)
- Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions (2019) (85)
- Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. (2003) (84)
- Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009–2012: Focus on children, adolescents and prescriber specialty (2014) (83)
- Differential anxiolytic efficacy of a benzodiazepine on first versus second exposure to a predatory odor in rats (1999) (80)
- Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice (2012) (80)
- Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey (2018) (80)
- A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine (2004) (79)
- Heterozygous neuregulin 1 mice display greater baseline and Δ9-tetrahydrocannabinol-induced c-Fos expression (2007) (74)
- Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence. (2013) (74)
- The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse. (2013) (74)
- Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat (2005) (73)
- Inflammation and Breakdown of the Blood–Retinal Barrier During “Physiological Aging” in the Rat Retina: A Model for CNS Aging (2007) (73)
- Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. (2007) (73)
- Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine‐seeking behaviour in rats (2016) (73)
- Oxytocin inhibits ethanol consumption and ethanol‐induced dopamine release in the nucleus accumbens (2017) (73)
- Heart rate variability predicts alcohol craving in alcohol dependent outpatients: further evidence for HRV as a psychophysiological marker of self-regulation. (2013) (73)
- The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain (2001) (72)
- Rewarding brain stimulation induces only sparse Fos-like immunoreactivity in dopaminergic neurons (1998) (72)
- The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. (2011) (71)
- Protein expression profile in the striatum of acute methamphetamine-treated rats (2006) (68)
- Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non‐peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats (2014) (68)
- Paraventricular hypothalamic CB1 cannabinoid receptors are involved in the feeding stimulatory effects of Δ9-tetrahydrocannabinol (2005) (68)
- Oxytocin prevents ethanol actions at δ subunit-containing GABAA receptors and attenuates ethanol-induced motor impairment in rats (2015) (67)
- Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome. (2019) (66)
- Neural activation during cat odor-induced conditioned fear and ‘trial 2’ fear in rats (2005) (66)
- The Cannabinoid Receptor Agonist THC Attenuates Weight Loss in a Rodent Model of Activity-Based Anorexia (2011) (65)
- The Nonpeptide Oxytocin Receptor Agonist WAY 267,464: Receptor‐Binding Profile, Prosocial Effects and Distribution of c‐Fos Expression in Adolescent Rats (2012) (65)
- Defensive responses of Wistar and Sprague-Dawley rats to cat odour and TMT (2006) (63)
- Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (“Ecstasy”) in rats (2004) (63)
- Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies. (2020) (62)
- Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake (2004) (62)
- Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial. (2020) (61)
- Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. (2003) (61)
- Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18) (2020) (60)
- Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine. (1998) (59)
- Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors (2019) (59)
- Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion (2012) (59)
- An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use (2017) (58)
- Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats (2018) (58)
- Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA (2018) (57)
- Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats. (2001) (56)
- Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS‐16) (2018) (56)
- Fear, risk assessment, and playfulness in the juvenile rat. (2006) (55)
- Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats (2004) (55)
- A comparison of Δ9-THC and anandamide induced c-fos expression in the rat forebrain (1998) (54)
- The distribution of γ-hydroxybutyrate-induced Fos expression in rat brain: Comparison with baclofen (2009) (54)
- MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. (2007) (52)
- Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial. (2019) (52)
- Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. (2004) (51)
- Oxytocin and vasopressin modulate the social response to threat: a preclinical study. (2014) (51)
- Regional c-Fos and FosB/ΔFosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats (2012) (51)
- On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA (2002) (50)
- Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. (2007) (49)
- Proteomic analysis demonstrates adolescent vulnerability to lasting hippocampal changes following chronic alcohol consumption. (2009) (48)
- Intermittent access to beer promotes binge-like drinking in adolescent but not adult Wistar rats. (2009) (47)
- Delta9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour. (2005) (47)
- The consequences of beer consumption in rats: acute anxiolytic and ataxic effects and withdrawal-induced anxiety (2003) (47)
- Predatory threat induces huddling in adolescent rats and residual changes in early adulthood suggestive of increased resilience (2011) (46)
- Moderate alcohol intake is related to increased heart rate variability in young adults: implications for health and well-being. (2013) (46)
- Rapid quantitation of fluoxetine and norfluoxetine in serum by micro-disc solid-phase extraction with high-performance liquid chromatography-ultraviolet absorbance detection. (2004) (46)
- The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol (2004) (45)
- Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716 (2004) (45)
- Intranasal oxytocin in the treatment of anorexia nervosa: Randomized controlled trial during re-feeding (2018) (45)
- High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)-induced Fos expression in a region-specific manner (2007) (44)
- The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine (2003) (44)
- MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635 (2011) (44)
- MDMA (‘Ecstasy’) and methamphetamine combined: Order of administration influences hyperthermic and long-term adverse effects in female rats (2005) (44)
- Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol. (2019) (44)
- Adolescent pre‐treatment with oxytocin protects against adult methamphetamine‐seeking behavior in female rats (2016) (43)
- Changes in cigarette and alcohol use during cannabis abstinence. (2014) (43)
- Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review (2021) (43)
- Protein expression profile in the striatum of rats with methamphetamine‐induced behavioral sensitization (2007) (42)
- Dopaminergic modulation of rat pup ultrasonic vocalizations. (1999) (42)
- Perinatal Exposure to Δ9-Tetrahydrocannabinol Alters Heroin-Induced Place Conditioning and Fos-Immunoreactivity (2006) (42)
- Regional differences in naloxone modulation of Δ9-THC induced Fos expression in rat brain (2003) (41)
- Beer consumption in rats: the influence of ethanol content, food deprivation, and cocaine. (1999) (41)
- Defensive Aggregation (Huddling) in Rattus Norvegicus toward Predator Odor: Individual Differences, Social Buffering Effects and Neural Correlates (2013) (41)
- The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis (2014) (41)
- Neural correlates of MDMA (“Ecstasy”)-induced social interaction in rats (2009) (40)
- Cannabichromene is a cannabinoid CB2 receptor agonist (2018) (40)
- Active coping toward predatory stress is associated with lower corticosterone and progesterone plasma levels and decreased methylation in the medial amygdala vasopressin system (2014) (39)
- Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function (2016) (39)
- Rats on the grog: novel pharmacotherapies for alcohol craving. (2004) (39)
- Access to cannabidiol without a prescription: A cross-country comparison and analysis. (2020) (39)
- Using Strawberry Tree WorkbenchMac and Workbench PC software for data acquisition and control in the animal learning laboratory (1996) (37)
- Involvement of hypothalamic peptides in the anorectic action of the CB1 receptor antagonist rimonabant (SR 141716) (2009) (37)
- Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents? (2011) (37)
- Metabolic effects of neuropeptide Y injected into the sulcal prefrontal cortex (1990) (36)
- Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues. (2017) (36)
- Chronic Methamphetamine Self‐Administration Dysregulates Oxytocin Plasma Levels and Oxytocin Receptor Fibre Density in the Nucleus Accumbens Core and Subthalamic Nucleus of the Rat (2016) (36)
- Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA. (2018) (36)
- Defensive behavior (2005) (35)
- Aggregation in quads but not pairs of rats exposed to cat odor or bright light (2012) (35)
- Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice (2013) (35)
- Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. (2005) (35)
- ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (2016) (34)
- Repeated exposure to Δ9-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity (2005) (34)
- Oxytocin and MDMA (‘Ecstasy’) enhance social reward in rats (2015) (34)
- Rats discriminate individual cats by their odor: Possible involvement of the accessory olfactory system (2008) (33)
- Automated scoring of novel object recognition in rats (2008) (33)
- The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement (2018) (33)
- Cocaine and heroin (‘speedball’) self-administration: the involvement of nucleus accumbens dopamine and μ-opiate, but not δ-opiate receptors (2005) (33)
- Long-lasting FosB/ΔFosB immunoreactivity in the rat brain after repeated cat odor exposure (2009) (32)
- Adolescent exposure to oxytocin, but not the selective oxytocin receptor agonist TGOT, increases social behavior and plasma oxytocin in adulthood (2014) (32)
- In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA (2017) (31)
- Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization (2008) (31)
- Disruptive effects of the prototypical cannabinoid &Dgr;9-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats (2011) (31)
- Co-administration of THC and MDMA (‘Ecstasy’) Synergistically Disrupts Memory in Rats (2005) (31)
- Long-term daily access to alcohol alters dopamine-related synthesis and signaling proteins in the rat striatum (2012) (31)
- Preliminary evidence for lowered basal cortisol in a naturalistic sample of methamphetamine polydrug users. (2012) (31)
- Exercise increases plasma THC concentrations in regular cannabis users. (2013) (30)
- Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation (1997) (30)
- Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination (2010) (30)
- A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain. (1998) (29)
- A Nose for Death: Integrating Trophic and Informational Networks for Conservation and Management (2016) (29)
- Parameters That Affect Fear Responses in Rodents and How to Use Them for Management (2019) (29)
- Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting (2014) (27)
- Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research (2020) (27)
- Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels (2020) (27)
- Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures (2018) (27)
- Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid Receptors (2018) (26)
- Neuroadaptations in the Striatal Proteome of the Rat Following Prolonged Excessive Sucrose Intake (2014) (26)
- Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats (2004) (25)
- Prescribing medicinal cannabis (2020) (24)
- CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist (2019) (24)
- Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point‐of‐collection testing devices (2019) (24)
- Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy (2021) (23)
- Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues (2015) (23)
- Contrasting effects of dopamine antagonists and frequency reduction on Fos expression induced by lateral hypothalamic stimulation (2002) (22)
- Hippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of “paradoxical” antidepressant responses in young persons (2013) (22)
- WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action (2015) (22)
- Interactions between cannabidiol and Δ9‐tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome (2020) (22)
- A long hangover from party drugs: Residual proteomic changes in the hippocampus of rats 8 weeks after γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination (2010) (22)
- Intravenous methamphetamine self-administration in rats: Effects of intravenous or intraperitoneal MDMA co-administration (2006) (22)
- Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats (2008) (22)
- Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA (2017) (22)
- Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry. (2009) (22)
- Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety. (2010) (21)
- A novel automated test battery reveals enduring behavioural alterations and cognitive impairments in survivors of murine pneumococcal meningitis (2014) (21)
- Chronic repetitive transcranial magnetic stimulation is antidepressant but not anxiolytic in rat models of anxiety and depression (2005) (20)
- Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain. (2003) (20)
- Inhaled vasopressin increases sociability and reduces body temperature and heart rate in rats (2014) (20)
- Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial (2020) (20)
- The failings of per se limits to detect cannabis-induced driving impairment: Results from a simulated driving study (2021) (20)
- Constrasting effects of dopaminergic blockade on MDMA and d-amphetamine conditioned taste aversions (1994) (20)
- ‘When an old rat smells a cat’: A decline in defense-related, but not accessory olfactory, Fos expression in aged rats (2011) (20)
- Metabolic effects obtained from excitatory amino acid stimulation of the sulcal prefrontal cortex (1990) (19)
- The Effects of Lithium Carbonate Supplemented with Nitrazepam on Sleep Disturbance during Cannabis Abstinence. (2015) (19)
- Preexposure to MDMA (“Ecstasy”) delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats (2004) (19)
- Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome. (2021) (19)
- Antipsychotic Induced Alteration of Growth and Proteome of Rat Neural Stem Cells (2012) (18)
- Regional c-Fos expression induced by peripheral oxytocin administration is prevented by the vasopressin 1A receptor antagonist SR49059 (2016) (18)
- Rubbings deposited by cats elicit defensive behavior in rats (2012) (18)
- Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial. (2020) (18)
- Urinary cannabinoid levels during nabiximols (Sativex®)-medicated inpatient cannabis withdrawal (2016) (18)
- Comparison of conditioned taste aversions produced by MDMA and d-amphetamine (1993) (18)
- Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia (2017) (17)
- Effects of typical (haloperidol) and atypical (risperidone) antipsychotic agents on protein expression in rat neural stem cells (2009) (17)
- Stressor-like effects of FG-7142 on medial prefrontal cortex self-stimulation (1990) (17)
- Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol (2018) (17)
- Metabolomics of Neurotransmitters and Related Metabolites in Post-Mortem Tissue from the Dorsal and Ventral Striatum of Alcoholic Human Brain (2016) (17)
- Driving on ice: impaired driving skills in current methamphetamine users (2012) (17)
- Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients (2020) (17)
- Absence of entourage: Terpenoids commonly found in Cannabis sativa do not modulate the functional activity of Δ9-THC at human CB1and CB2 receptors (2019) (16)
- Beer promotes high levels of alcohol intake in adolescent and adult alcohol-preferring rats. (2011) (16)
- An automated two-choice test of olfactory working memory in the rat: Effect of scopolamine (2000) (16)
- Asymmetric suppression of components in binary aldehyde mixtures: behavioral studies in the laboratory rat. (2006) (15)
- Metabolic changes associated with ingestion of different macronutrients and different meal sizes in rats (1995) (15)
- Prefrontal cortex α 2 adrenoceptors and energy balance (1991) (15)
- High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats (2008) (15)
- Antidepressants and adolescent brain development (2011) (15)
- Functional genomics of epilepsy-associated mutations in the GABAA receptor subunits reveal that one mutation impairs function and two are catastrophic (2019) (14)
- Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV) (2018) (14)
- Prefrontal cortex self-stimulation and energy balance. (1991) (14)
- Comparative proteomics in the corpus callosal sub-regions of postmortem human brain (2009) (14)
- Altered behaviour and cognitive function following combined deletion of Toll-like receptors 2 and 4 in mice (2016) (13)
- The Major Plant-derived Cannabinoid Δ9-Tetrahydrocannabinol Promotes Hypertrophy and Macrophage Infiltration in Adipose Tissue (2011) (13)
- Driving-Related Behaviours, Attitudes and Perceptions among Australian Medical Cannabis Users: Results from the CAMS 18-19 Survey. (2020) (13)
- The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs. (2019) (13)
- Cocaine facilitation of prefrontal cortex self-stimulation: a microstructural and pharmacological analysis (2007) (12)
- Gain-of-function GABRB3 variants identified in vigabatrin-hypersensitive epileptic encephalopathies (2020) (12)
- Stress-induced changes in respiratory quotient, energy expenditure and locomotor activity in rats: effects of midazolam (1994) (12)
- Cannabis reward: biased towards the fairer sex? (2007) (12)
- Interleukin-18 deficiency and its long-term behavioural and cognitive impacts in a murine model of pneumococcal meningitis (2014) (12)
- MDMA (‘Ecstasy’), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors (2016) (12)
- Medical cannabis and driving. (2021) (11)
- Evaluation of the Possible Anticonvulsant Effect of Δ9-Tetrahydrocannabinolic Acid in Murine Seizure Models (2020) (11)
- Are blood and oral fluid Δ9-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis (2021) (11)
- Footshock stress facilitates self-stimulation of the medial prefrontal cortex but not the lateral hypothalamus in the rat (1989) (11)
- Antibody-induced neutrophil depletion prior to the onset of pneumococcal meningitis influences long-term neurological complications in mice (2016) (11)
- Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18. (2018) (10)
- Cocaine and heroin ('speedball') self-administration: the involvement of nucleus accumbens dopamine and mu-opiate, but not delta-opiate receptors. (2005) (10)
- Medicinal cannabis and driving: the intersection of health and road safety policy. (2021) (10)
- Sleeplessness (1885) (10)
- Medicinal cannabis in the treatment of chronic pain. (2021) (9)
- Contrasting effects of stress on medial and sulcal prefrontal cortex self-stimulation (1991) (9)
- The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol (2020) (9)
- The chemistry and pharmacology of synthetic cannabinoid SDB-006 and its regioisomeric fluorinated and methoxylated analogs. (2018) (9)
- Benzodiazepines impair the acquisition and reversal of olfactory go/no-go discriminations in rats. (2007) (9)
- Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial (2022) (9)
- The kynurenine pathway contributes to long-term neuropsychological changes in experimental pneumococcal meningitis (2014) (9)
- Weekly γ-Hydroxybutyrate Exposure Sensitizes Locomotor Hyperactivity to Low-Dose 3,4-Methylenedioxymethamphetamine in Rats (2009) (8)
- Determinants of the slow acquisition of medial and sulcal prefrontal cortex self-stimulation: An individual differences approach (1992) (8)
- Changes in Respiratory Quotient Elicited in Rats by a Conditioned Stimulus Predicting Food (1998) (8)
- Environment-specific conditioning produced by electrical stimulation of the lateral hypothalamus (1989) (7)
- Pyrazolo[1,4]diazepines as non-peptidic probes of the oxytocin and vasopressin receptors (2014) (7)
- Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years (2022) (7)
- The effect of COVID19 pandemic restrictions on an urban rodent population (2021) (7)
- Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial. (2022) (7)
- In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018 (2020) (6)
- Citalopram and Cannabidiol (2021) (6)
- Regional Fos-expression induced by γ-hydroxybutyrate (GHB): Comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382 (2014) (6)
- Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials (2021) (6)
- Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences (2014) (6)
- Cannabinoids, insomnia, and other sleep disorders. (2022) (6)
- Contrasting regional Fos expression in adolescent and young adult rats following acute administration of the antidepressant paroxetine (2016) (6)
- Erratum to: The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain [Brain Research 921 (2001) 240–255] (2002) (6)
- Double deficiency of toll-like receptors 2 and 4 alters long-term neurological sequelae in mice cured of pneumococcal meningitis (2019) (6)
- Determination of contaminants in artisanal cannabis products used for childhood epilepsy in the Australian community: A sub-analysis of the ‘PELICAN’ study (2021) (5)
- Structure-activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA. (2022) (5)
- NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity? (2021) (5)
- A validated method for the simultaneous quantification of CBD, THC, and their metabolites in human plasma, and application to plasma samples from an oral CBD open label trial. (2020) (5)
- Behavioral and cognitive data in mice with different tryptophan-metabolizing enzymes knocked out (2016) (5)
- Labs make new, dangerous synthetic cannabinoid drugs faster than we can ban them (2015) (5)
- Cannabidiol for at risk for psychosis youth: A randomized controlled trial (2021) (5)
- Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20) (2022) (4)
- Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease (2020) (4)
- Erratum to: In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA (2017) (4)
- Low and high doses of midazolam differentially affect hypoalgesia in rats conditioned to a heat stressor (2005) (4)
- Cannabichromene and Δ9-Tetrahydrocannabinolic Acid Identified as Lactate Dehydrogenase-A Inhibitors by in Silico and in Vitro Screening. (2021) (4)
- Controllability of prestimulation of the medial prefrontal cortex determines the facilitation of self-stimulation and kindled seizures (1989) (4)
- Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome (2022) (4)
- Randomised controlled trial (RCT) of daily aerobic exercise for inpatient cannabis withdrawal: A study protocol (2017) (4)
- Oxytocin, Vasopressin and Related Peptides in the Regulation of Behavior: Oxytocin and addiction (2013) (4)
- The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence (2022) (3)
- Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition. (2022) (3)
- P2X7 in Bipolar and Depressive Disorders (2014) (3)
- Antipredator responses toward cat fur in wild brown rats tested in a semi-natural environment (2021) (3)
- Taste-potentiated odor aversion learning based on amphetamine (1993) (3)
- Orally administered cannabidiol does not produce false‐positive tests for Δ9‐tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000 (2021) (3)
- Give me a hi-5! An additional version of the h-index (2013) (3)
- Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female rats (2022) (3)
- Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting (2014) (3)
- Defining Steric Requirements at CB1 and CB2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues. (2022) (3)
- A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function (2022) (3)
- International conference on memory (ICOM-4), University of New South Wales, Sydney, Australia, 16—21 July 2006 Ecstasy/MDMA and Memory Symposium (2007) (3)
- The anticonvulsant zonisamide positively modulates recombinant and native glycine receptors at clinically relevant concentrations (2020) (3)
- Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis (2022) (2)
- Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (CaV3) Inhibitors. (2022) (2)
- Prefrontal cortex alpha 2 adrenoceptors and energy balance. (1991) (2)
- The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial (2020) (2)
- Effects of Cannabidiol on Exercise Physiology and Bioenergetics: A Randomised Controlled Pilot Trial (2022) (2)
- The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels (2022) (2)
- Sex-specific transcriptomic and epitranscriptomic signatures of PTSD-like fear acquisition (2021) (2)
- Cortisol response and psychological distress predict susceptibility to false memories for a trauma film (2016) (2)
- An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma (2022) (1)
- Driving Impairment Following Vaporization of Cannabis-Reply. (2021) (1)
- Medicinal cannabis for the treatment of anxiety disorders. (2022) (1)
- A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine: A Case Report. (2022) (1)
- The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogues (2018) (1)
- Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses (2022) (1)
- The impact of Sativex® on cognitive function during treatment for cannabis withdrawal (2014) (1)
- A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis (2022) (1)
- Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial. (2022) (1)
- SPECIAL ISSUE ARTICLE ∆ 9 -THC REINSTATES BEER- AND SUCROSE-SEEKING BEHAVIOUR IN ABSTINENT RATS: COMPARISON WITH MIDAZOLAM, FOOD DEPRIVATION AND PREDATOR ODOUR (2005) (1)
- Subject Index Vol. 60, 2009 (2009) (1)
- Repeated exposure to a cannabinoid receptor agonist alters subsequent basal and morphine induced fos immunoreactivity (2002) (1)
- Excitatory Amino Acids and Their Antagonists (2015) (1)
- WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action (2015) (0)
- S.12.1 - CANNABINOIDS: A RISK FACTOR FOR A GENETIC MOUSE MODEL OF SCHIZOPHRENIA? (2013) (0)
- P-11-15 Induction of immediate early genes following rewarding brain stimulation (1996) (0)
- Metabolomics of Neurotransmitters and Related Metabolites in Post-Mortem Tissue from the Dorsal and Ventral Striatum of Alcoholic Human Brain (2016) (0)
- Contents Vol. 60, 2009 (2009) (0)
- Ecstacy, 'ice' and polydrug use: Long term behavioural effects in rats (2007) (0)
- Acute and Long-Term Behavioural Effects of MDMA in Adolescent Rats (2011) (0)
- The Effect Of Cannabidiol (CBD) On Exercise Physiology And Bioenergetics: A Randomised Controlled Pilot Trial (2021) (0)
- Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channels (2023) (0)
- Neural circuitry activated by the unexpected withdrawal of self-administered methamphetamine in rats (2005) (0)
- γ-Hydroxybutyrate and 3,4-methylenedioxymethamphetamine combinations: effects on body temperature, behavior, and brain monoamine content in rats (2005) (0)
- MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy (2023) (0)
- Methamphetamine or MDMA pretreatment effects subsequent methamphetamine self-administration and MDMA-induced reinstatement in rats (2005) (0)
- Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11 (2022) (0)
- S33 MDMA, METHAMPHETAMINE AND THEIR COMBINATION: COMPARISON OF LONG-TERM BEHAVIOURAL AND NEURAL EFFECTS IN RATS (2005) (0)
- Antipsychotic Induced Alteration of Growth and Proteome of Rat Neural Stem Cells (2012) (0)
- Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs (2022) (0)
- Muscarinic Cholinergic Receptor Agonists and Antagonists (2015) (0)
- Mephedrone ('meow'): recent studies using animal models (2011) (0)
- Oxytocin and MDMA (‘Ecstasy’) enhance social reward in rats (2015) (0)
- Driving on ice: impaired driving skills in current methamphetamine users (2012) (0)
- Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition (2019) (0)
- Neuroadaptations in the Striatal Proteome of the Rat Following Prolonged Excessive Sucrose Intake (2014) (0)
- P.6.a.003 Oxytocin potently antagonises behavioural and neuronal ethanol effects: involvement of GABAA δ subunit-containing receptors (2014) (0)
- Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder (2022) (0)
- Response to: ‘Cannabis use before safety sensitive work: What delay is prudent?’ (2022) (0)
- Cannabis use and non-cancer chronic pain. (2018) (0)
- Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa (2021) (0)
- The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients (2021) (0)
- AN ANIMAL MODEL OF A GENE-ENVIRONMENT INTERACTION: THE ROLE OF NRG1 IN CANNABIS-INDUCED SCHIZOPHRENIA (2010) (0)
- Marijuana addiction. (1997) (0)
- Laterodorsal tegmentum modulation of nucleus accumbens dopamine release analysed in real time (2001) (0)
- -Tetrahydro- cannabinol Promotes Hypertrophy and Macrophage Infi ltration in Adipose Tissue (2012) (0)
- Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses (2022) (0)
- Advances in addiction neurobiology: decision-making, cannabis and oxytocin (2013) (0)
- Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV). (2020) (0)
- Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences (2014) (0)
This paper list is powered by the following services:
